Navigation Links
Focus on Rapid Medical Response to Improve the Quality of Healthcare and Drive the Ambulance Services Market in Europe, According to Frost & Sullivan
Date:5/14/2009

em - including land-, air- and boat-based emergency services. Efforts are ongoing to enhance such services with additional staff training and the inclusion of advanced technologies.

Healthcare authorities are aware of the importance of having a highly developed ambulance service. However, the sector is plagued by complex legislation and regulations at regional levels, usually related to ambulance equipment and staff requirements/training. In addition, advanced technologies such as telemedicine and GIS are dependent on regional regulations, making it harder for their effective integration with ambulances.

"It is important for healthcare systems to focus on providing immediate relief to patients, rather than make changes to regulations," states Frost & Sullivan. "As time is the most important factor in saving a patient's life, incorporating advanced technologies will drastically reduce mortality rates."

For medical device manufacturers, the best way to optimise the ambulance market for their products is to design their products such that they work durably within the rough environment of an ambulance.

"Medical devices are used within the ambulance while it is in motion and hence more emphasis is given to features such as ruggedness, compactness, short start time and easy training," concludes the Frost & Sullivan research. "Equally important is the ability to be hooked to an IT system or telemedicine network."

If you are interested in a virtual brochure, which provides a brief synopsis of the research and a table of contents, then send an e-mail to Katja Feick, Corporate Communications, at katja.feick@frost.com, with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country.
'/>"/>

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
2. Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion
3. Education Key Focus of Michigan Policy Summit
4. Heart Failure Society of America 11th Annual Scientific Meeting to Focus on Heart Failure Guidelines, Innovation and New Research
5. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
6. This October, the American Physical Therapy Associations National Physical Therapy Month to Focus on Nations Obesity Epidemic
7. DuPont Focused on Meeting Global Demands for Greater Safety & Protection
8. New Seminar Series from Activator Methods Teaches Doctors a Unique Approach to Improving Nations Chiropractic Care: Focus on the Patients
9. Growing Link Between Diabetes and Periodontal Disease Focus of National Gathering for Health Care Leaders
10. AUDIO from Medialink and Bayer: Simple, Focused Ways to Boost Womens Health
11. Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)... and Crushing Taxes Nail Nation,s Job Creators ,...n response to U.S. House passage of the health car...eurship Council (SBE Council) president & CEO ..., "Make no mistake, those voting for H.R. 3962 v...er costs and crushing taxes and penalties. Even in...
(Date:11/8/2009)... Freeze-drying of biopharmaceuticals to be ...rio facility. , Toronto,...esident and CEO of Therapure Biopharma Inc. today ... commercial scale pharmaceutical grade freeze drye...ng (lyophilization) available for contract manufac...
(Date:11/8/2009)...rgest network of Hispanic health advocates committ...009 ,, WASHINGTON, Nov. 7 /PRNewswire-USNewswi...showed they have heard the voice of America,s fami...rica Act. Now the Senate must deliver, without del...m," said Dr. Jane L. Delgado, President and CEO of...
(Date:11/8/2009)...s House Passage of Health Care Reform Bill ,, ...mprove coverage for all Americans ,, CHICAGO, ...d States House of Representatives passed by a vote...on that would strengthen Medicare for seniors and ...ces millions of Americans out of affordable health...
(Date:11/7/2009)... Nov. 7 Speaker Nanc... of H.R. 3962, the Affordable Health Care for Amer...ater tonight. Below are the Speaker,s remarks. ,...historic moment for our nation and for American fa...rty and political philosophy -- as far back as Ted...
Breaking Medicine News(10 mins):Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4
...ing sucrose to reduce pain in newborns undergoing ...ing blood taken (venipuncture) for the newborn scr...write Dr. Anna Taddio and co-authors. , In this ...ewborns when administered before painful medical p...
...-Topping Recording Artist Has Partnered with Music...port of the Heightened National Response to ...une 30 Platinum selling,singer/songwriter/produce...ur, Lyfe is partnering with Music World,Entertainm...
...: THE (mostly) BIG THOUGHTS EDITION (p. 26). In th...tions, collects factoids and writes essays,on topi... whether having,children makes you happier and whe...overed in the issue. Try these:, 1. How many pres...
... Americans die each year waiting for a replacement... 29 (HealthDay News) -- More than 98,000 Americans...only chance for survival is a dead person,s genero...for a replacement organ that never arrived, accord...
...E, Calif., June 28 Western Growers is,urging the ... soon as,possible on the salmonella outbreak that ... plum tomatoes., FDA and CDC have been unable to ...ing irreparable harm., "Congress must investigate...
...anadian study finds increase in non-serious side e... -- Drugs that contain compounds called cannabinoi...k of serious side effects but are associated with ...tish Columbia (UBC) examined adverse events report...
Other Medicine News:Health News:Lyfe Jennings Launches Summer Tour and HIV/AIDS Awareness Initiative 2Health News:NEWSWEEK: Media Lead Sheet - July 7-14, 2008 Double Issue (On Newsstands Monday, June 30) 2Health News:NEWSWEEK: Media Lead Sheet - July 7-14, 2008 Double Issue (On Newsstands Monday, June 30) 3Health News:NEWSWEEK: Media Lead Sheet - July 7-14, 2008 Double Issue (On Newsstands Monday, June 30) 4Health News:NEWSWEEK: Media Lead Sheet - July 7-14, 2008 Double Issue (On Newsstands Monday, June 30) 5Health News:Organ Donation: An Advancing Science Hindered by Supply Shortages 2Health News:Organ Donation: An Advancing Science Hindered by Supply Shortages 3Health News:Western Growers Asks for Congressional AG Committee Hearings Regarding Salmonella Outbreak and Investigations 2Health News:Drugs With Marijuana Compounds Don't Boost Adverse Events 2
(Date:11/6/2009)...,, - Trial Will Compare NXL103 With Leading...esistant Staphylococcus Aureus (MRSA) Infections ,...pany focused on the discovery and,development of n...ant global,problem of microbial resistance, announ...l NXL103 (flopristin/linopristin), has started a P...
(Date:11/5/2009)...ea Technologies, Inc., a leading provider of devel...tical products announced the addition of customize...m of services, which will be overseen by the newly...tion Development. This investment in an experience...long with new laboratory facilities and state-of-t...
(Date:11/5/2009)...stCall/ -- Helix BioPharma Corp. (TSX, FSE: "HBP" ...trial of Topical Interferon Alpha-2b for the treat...ent enrollment, with the required 120th patient ra...d and placebo-controlled Phase II trial is underwa...ents participating in the trial self-administer ac...
Breaking Medicine Technology:Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services 2Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 2Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 3Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 4Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 5Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 6Adnavance Technologies to Present Initial Data Supporting Direct Detection Molecular Diagnostic Tests at AdvaMed 2009 and BIOCOM Investor Conference 5333 1Adnavance Technologies to Present Initial Data Supporting Direct Detection Molecular Diagnostic Tests at AdvaMed 2009 and BIOCOM Investor Conference 5333 2BMEYE B V Completes EUR 6 Million Series B Financing Round 5329 1BMEYE B V Completes EUR 6 Million Series B Financing Round 5329 2BMEYE B V Completes EUR 6 Million Series B Financing Round 5329 3Advanced Health Media Announces Acquisition of Ephikacy LLC 5324 1Advanced Health Media Announces Acquisition of Ephikacy LLC 5324 2Advanced Health Media Announces Acquisition of Ephikacy LLC 5324 3
...d YONGIN, South Korea, Jan. 12 Jennerex,Inc. (San... Korean partner,Green Cross Corp., today announced... primary liver cancer clinical trial using its tar...xicities were reported, and enrollment of,patients...rial involves treatment of patients with advanced,...
... 12 Cara Therapeutics, Inc. today announced that ...long-acting peripheral kappa opioid agonist, CR845...-controlled trial will be conducted in the United ...d safety of intravenous CR845 during the post-oper...ted hysterectomy. The trial is expected to enroll ...
Other Medicine Technology:Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer 2Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer 3Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer 4Cara Therapeutics Initiates Phase II Proof-Of-Concept Trial of Novel Analgesic in Acute Post-Operative Pain 2
27 Gauge Air Injection Cannula
Reverse Double Barreled Irrigation/Aspiration Set
Irrigation/Aspiration Cannula
Infusion Lens Loop
Medicine Products: